Scarica l'app Stockscreener
6.31
2.44%
0.15
Dopo l'orario di chiusura:
6.31
Precedente Chiudi:
$6.16
Aprire:
$6.29
Volume 24 ore:
6,482
Relative Volume:
0.25
Capitalizzazione di mercato:
$19.72M
Reddito:
$11.68M
Utile/perdita netta:
$-8.85M
Rapporto P/E:
-2.6183
EPS:
-2.41
Flusso di cassa netto:
$-14.61M
1 W Prestazione:
+16.85%
1M Prestazione:
-15.53%
6M Prestazione:
+217.09%
1 anno Prestazione:
+213.15%
Intervallo 1D:
$6.27
$6.40
Intervallo di 1 settimana:
$5.40
$6.515
Portata 52W:
$1.72
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Nome
Pulmatrix Inc
Settore
Industria
Telefono
(888) 355-4440
Indirizzo
945 CONCORD STREET, FRAMINGHAM, MA
Confronta PULM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
6.31 | 19.72M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
490.47 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.49 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
599.87 | 36.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
236.75 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
252.77 | 25.74B | 3.81B | -644.79M | -669.77M | -6.24 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-02-09 | Iniziato | H.C. Wainwright | Buy |
Pulmatrix Inc Borsa (PULM) Ultime notizie
(PULM) Investment Analysis - news.stocktradersdaily.com
Pulmatrix appoints CBIZ as new auditor after Marcum resignation By Investing.com - Investing.com India
Pulmatrix appoints CBIZ as new auditor after Marcum resignation - Investing.com
Pulmatrix Will Discuss Progress At The Aegis Growth Conference On September 21, 2016 - BioSpace
Aspergillosis Market on Track for Major Expansion by 2034, According to DelveInsight | F2G, Pulmatrix, TFF Pharmaceuticals, Scynexis, Pulmocide - The Globe and Mail
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - ACCESS Newswire
Pulmatrix : Reports 2018 Financial Results; Provides 2019 Outlook on Pulmonary Disease Pipeline - MarketScreener
Learn to Evaluate (PULM) using the Charts - news.stocktradersdaily.com
Pulmatrix Reports 2024 Financials and Merger Plans - TipRanks
Pulmatrix Announces Divestment Plan for Assets - citybiz
Pulmatrix Inc. (PULM) reports earnings - Quartz
Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets - Nasdaq
Pulmatrix (NASDAQ:PULM) Stock Price Crosses Above Fifty Day Moving Average – What’s Next? - Defense World
(PULM) Trading Report - Stock Traders Daily
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, PULM, CCNE, TURN on Behalf of Shareholders - The Malaysian Reserve
2025-02-25 | SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, PULM, CCNE, TURN on Behalf of Shareholders | NDAQ:CCNE | Press Release - Stockhouse
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Pulmatrix, Inc. (PULM) - TradingView
PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders - Business Wire
PULM stock soars to 52-week high, touches $8.5 amid robust gains - Investing.com India
PULM stock soars to 52-week high, touches $8.5 amid robust gains By Investing.com - Investing.com South Africa
Pulmatrix revises bylaws, changes voting standards - MSN
Pulmatrix revises bylaws, changes voting standards By Investing.com - Investing.com Nigeria
(PULM) Proactive Strategies - Stock Traders Daily
Pulmatrix's Unique Inhaled Drug Candidate Has "Blockbuster" Potential, Says CFO Bill Duke - ACCESS Newswire
Cullgen Begins Phase 1 Dosing of its Potential First-in-Class, Oral Pan-TRK Protein Degrader for Acute and Chronic Pain - The Manila Times
SEC Form 425 filed by Pulmatrix Inc. - Quantisnow
Cullgen Begins Phase 1 Dosing of its Potential - GlobeNewswire
Aspergillosis Market Expected to rise, 2034 | Regeneron, Pulmocide, Astellas Pharma, Cipla, Pulmatrix, F2G, Cellix Bio, SCYNEXIS, TFF, Matinas BioPharma, Amplyx Pharmaceuticals, Cidara Therapeutics, I - The Globe and Mail
Pulmatrix (NASDAQ:PULM) Coverage Initiated by Analysts at StockNews.com - Defense World
Pulmatrix (NASDAQ:PULM) Earns Hold Rating from Analysts at StockNews.com - Defense World
Pulmatrix, Inc. Holds 2024 Annual Meeting of Stockholders – Final Voting Results Released - Defense World
Pulmatrix secures director positions and ratifies accounting firm - Investing.com India
Pulmatrix secures director positions and ratifies accounting firm By Investing.com - Investing.com Australia
StockNews.com Begins Coverage on Pulmatrix (NASDAQ:PULM) - Defense World
Pulmatrix (NASDAQ:PULM) Now Covered by StockNews.com - Defense World
Cullgen Entering Public Market with Pulmatrix Merger - San Diego Business Journal
Pulmatrix Announces Third Quarter 2024 Financial Results and Pro - GuruFocus.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, ALVR, PULM, ENTO on Behalf of Shareholders - The Malaysian Reserve
Finansavisen - Finansavisen
Pulmatrix and Cullgen announce proposed merger - MSN
Stock Market News: Samfine Creation Holdings drops by 21.56% while Pulmatrix dropped by almost 15% during mid day trading - Business Upturn
Pulmatrix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Pulmatrix (NASDAQ:PULM) Coverage Initiated at StockNews.com - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc.PULM - Marketscreener.com
Pulmatrix (STU:2PU) Dividends per Share : €0.00 (TTM As of Jun. 2024) - GuruFocus.com
Pulmatrix Shares Hit 52-Week High After News of Merger Deal - MarketWatch
Zai Lab aims to raise $200M; Kronos Bio to seek ‘strategic’ options - Endpoints News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM, ENTO, PIK, PFC on Behalf of Shareholders - AccessWire
U.S. Stock market top gainers: AgEagle Aerial Systems surges by 151.55% while Gaxos.ai Inc gains 47.58% in ealry trading - Business Upturn
Pulmatrix Inc Azioni (PULM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):